New diabetes pill tested in major chinese trial
NCT ID NCT02916706
Summary
This study tested whether the drug teneligliptin helps control blood sugar in adults with type 2 diabetes. 254 Chinese participants were randomly assigned to receive either the drug or a placebo pill for 24 weeks while continuing their usual diet and exercise. Researchers measured changes in blood sugar levels to see if the drug was effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational center
Beijing, China
Conditions
Explore the condition pages connected to this study.